Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer.
Mistretta FA, Carrion DM, Nazzani S, Vásquez JL, Fiori C, De Cobelli O, Porpiglia F, Esperto F. Mistretta FA, et al. Among authors: nazzani s. Minerva Urol Nefrol. 2019 Jun;71(3):191-200. doi: 10.23736/S0393-2249.19.03311-3. Epub 2019 Jan 17. Minerva Urol Nefrol. 2019. PMID: 30654603 Free article. Review.
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI. Nazzani S, et al. World J Urol. 2019 Jul;37(7):1329-1337. doi: 10.1007/s00345-018-2516-z. Epub 2018 Oct 8. World J Urol. 2019. PMID: 30298285
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
Mistretta FA, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI. Mistretta FA, et al. Among authors: nazzani s. Cancer Epidemiol. 2019 Apr;59:135-142. doi: 10.1016/j.canep.2019.02.002. Epub 2019 Feb 13. Cancer Epidemiol. 2019. PMID: 30771698
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI. Nazzani S, et al. Clin Genitourin Cancer. 2019 Jun;17(3):e602-e611. doi: 10.1016/j.clgc.2019.03.003. Epub 2019 Mar 29. Clin Genitourin Cancer. 2019. PMID: 31005472
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA, Cyr SJ, Luzzago S, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI. Mistretta FA, et al. Among authors: nazzani s. Clin Genitourin Cancer. 2020 Apr;18(2):129-137.e3. doi: 10.1016/j.clgc.2019.09.008. Epub 2019 Sep 26. Clin Genitourin Cancer. 2020. PMID: 32001182
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Montanari E, Acquati P, Briganti A, Carmignani L, Karakiewicz PI. Nazzani S, et al. Clin Genitourin Cancer. 2019 Feb;17(1):e97-e103. doi: 10.1016/j.clgc.2018.09.017. Epub 2018 Sep 27. Clin Genitourin Cancer. 2019. PMID: 30337106
72 results